Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals
Clinical Benefit
| Substantial |
Le service médical rendu par COSOPT 20 mg/5 ml/ml, collyre en solution en récipient unidose, est important.
|
Clinical Added Value
| no clinical added value |
COSOPT 20 mg/5 mg/ml, collyre en solution en récipient unidose, n'apporte pas d'amélioration du service médical rendu (niveau V) par rapport COSOPT, collyre en solution en flacon multidose.
|
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
mMm4Yr3HHvRQLeue
